Authors: Mortimore, M Gibson, PR Selby, WS Radford-Smith, GL Florin, THJ

Citation: M. Mortimore et al., Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?, INTERN M J, 31(3), 2001, pp. 146-150

Authors: Bowen, DG Selby, WS

Citation: Dg. Bowen et Ws. Selby, Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine, DIG DIS SCI, 45(9), 2000, pp. 1810-1813

Authors: Macumber, C Phan, TG Young, GAR Selby, WS

Citation: C. Macumber et al., Myelofibrosis presenting as splenic tumor, DIG DIS SCI, 44(9), 1999, pp. 1817-1822

Authors: Selby, WS Painter, D Collins, A Faulkner-Hogg, KB Loblay, RH

Citation: Ws. Selby et al., Persistent mucosal abnormalities in coeliac disease are not related to theingestion of trace amounts of gluten, SC J GASTR, 34(9), 1999, pp. 909-914

Authors: Faulkner-Hogg, KB Selby, WS Loblay, RH

Citation: Kb. Faulkner-hogg et al., Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: The role of trace amounts of gluten and non-gluten food intolerances, SC J GASTR, 34(8), 1999, pp. 784-789